ARCHIVES

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

This article is from The Cancer Letter archive.

Vol. 07 No. 47 | November 20, 1981

Download PDF Visit The Full Archive

Related Articles

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

Center Directors Urge NCI To Expand CTEP’s Treatment Referral Cntr.

March 12, 1993

Levamisole/5-FU Could Save $226 Mil. If Fully Adopted, NCI Economist Says

April 20, 1990

The Education Of Dan Flood Gets $60 Million Increase For NCI; House Votes HEW Money Bill

July 5, 1974

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

November 26, 2014